Since the PD-1/PD-L1 pathway is involved in immune evasion and tumor progression, many researchers have conducted in-depth research into whether the expression level of PD-1 and PD-L1 protein in tumor tissues is related to the clinical characteristics and biological behavior of HNSCC. Here, CD274 is linked to neoplasm.